Oncology CME

Credits: 0.75 CME / MOC / NCPD / CC
Medical Learning Institute, Inc.
Optimizing Care for High-Risk Myeloid Cancers: Interprofessional Team Insights From a Center of Excellence
April 14, 2021
Credits: 0.75 CME
Medical Learning Institute, Inc.
At the Nexus of Locoregional and Systemic Liver Cancer Therapy: A Multidisciplinary Tumor Board on Improving Outcomes in Intermediate to Advanced HCC
April 14, 2021
Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
Precision Decisions in Genomic Testing and Targeted Treatment of NSCLC
April 13, 2021
Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
HER2 and HER3 Alterations as Therapeutic Targets of Increasing Significance in Solid Tumors: Implications for Pathology and Oncology Practice
April 6, 2021
Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
The Nuances of Immunotherapy Biomarker Testing in Solid Tumors: Unraveling Complexities and Overcoming Challenges to Improve Outcomes
April 5, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Conversations on the New Wave of Innovative Therapy in Follicular Lymphoma: Implications for Personalized Medicine
April 5, 2021
Credits: 0.50 CME / MOC / CE
Medical Learning Institute, Inc.
Innovative Blood-Based Screening in Cancer Care: State of the Science and Future Opportunities for Accelerating Cancer Diagnoses
March 18, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
RCC MasterClass and Clinical Consult: Remodeling the Treatment Algorithm With Novel Immune and Targeted Therapies
March 4, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Examining the State of the Science on New Therapies in Bladder Cancer: Perspectives on the Latest Developments Across the Disease Continuum
March 3, 2021
Credits: 1.00 CME
The Medical College of Wisconsin
How to Manage JAK Inhibition in Patients Undergoing HCT: Applying the Latest Clinical Evidence to Improve Patient Outcomes in Myelofibrosis
February 26, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Expanding the Benefits of Immuno-Oncology to More Patients With Solid Tumors Through Novel Rational Targets and Combinations
February 24, 2021
Credits: 1.00 CME
The Medical College of Wisconsin
New Perspectives in Acute and Chronic GVHD: Challenges and Opportunities for Improving Prophylaxis and Treatment With Novel Therapeutics
February 23, 2021
Credits: 1.00 CME
The Medical College of Wisconsin
The Multiple Myeloma Workshop: Exploring the Convergence of Novel Therapeutic Platforms, Cell Therapy, and ASCT
February 17, 2021
Credits: 1.00 CME
The Medical College of Wisconsin
Charting Progress in AML Care: A Clinical CaseBook on the Intersection of Novel Therapy and Allogeneic HCT
February 16, 2021
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
How I Think, How I Treat: Remodeling the HCC Treatment Algorithm With New and Emerging Monotherapy, Combination, and Multimodal Approaches
February 9, 2021
Credits: 1.75 CME / MOC
Medical Learning Institute, Inc.
Taking Aim at GI Cancers: New Opportunities to Deliver Personalized Treatment With HER2 and Other Molecularly Targeted Therapies
February 8, 2021
Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
New Horizons in EGFR-Mutated NSCLC: Broadening the Impact of Precision Testing in the Context of an Expanding Treatment Landscape
January 26, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
A Visual Exploration of New Opportunities in Thyroid Cancer: Targeting RET Alterations to Optimize Outcomes
December 30, 2020
Credits: 1.00 CME
Medical Learning Institute, Inc.
Targeting Ocular Toxicity in Multiple Myeloma: Opportunities for Ophthalmology-Oncology Collaboration
December 29, 2020

Pages